Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Plos One|March 9, 2026
Patient and injection partner perspectives on barriers and facilitators to home-based administration of long-acting injectable antiretroviral therapyAlicia T Bolton, Beth Bourdeau, Greg Rebchook, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 19, 2025
Real-World Positive Predictive Value and False Positive Rates of Laboratory-Based HIV Antigen/Antibody Testing by Age and Sex - United States, 2019-2024Weiming Zhu, Patricia Bessler, Allison Lale, et al.
AIDS (London, England)|February 6, 2025
Impact of increased uptake of long-acting injectable antiretroviral therapy on HIV incidence and viral suppression in the United States under 2021 FDA guidelinesAlex Viguerie, Jesse O'Shea, Marie Johnston, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2025
Trends in Persons Prescribed HIV Postexposure Prophylaxis in the United States, 2015-2023John N Le, Weiming Zhu, Ya-Lin A Huang, et al.
BMJ Open|August 5, 2025
Innovative administration of long-acting injectables for HIV treatment enhancement at home (INVITE-HOME): implementation science study protocolBeth Bourdeau, Greg Rebchook, Starley B Shade, et al.
Plos One|June 12, 2026
"Picking the right person … can make or break the whole deal": Development of a layperson injector selection tool for administration of home-based long-acting injectable antiretroviral therapiesBeth Bourdeau, Alicia T Bolton, Michelle Palomares, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2020
Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019Boghuma K Titanji, Monica M Farley, Ashish Mehta, et al.
The Journal of Infectious Diseases|November 29, 2023
Prolonged Mpox Disease in People With Advanced HIV: Characterization of Mpox Skin LesionsJesse O'Shea, Jason Zucker, Samuel Stampfer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 22, 2023
The Cooperative Re-Engagement Controlled Trial (CoRECT): Durable Viral Suppression AssessmentJesse O'Shea, Robyn Neblett Fanfair, Tiffany Williams, et al.
The Journal of Infectious Diseases|October 20, 2023
How the Orthodox Features of Orthopoxviruses Led to an Unorthodox Mpox Outbreak: What We've Learned, and What We Still Need to UnderstandJohn T Brooks, Mary G Reynolds, Elizabeth Torrone, et al.
Pageof 3